Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Introduction Move the world with us! Wake up each day to be part of a global movement.A movement tomake an impact. A movement togo for it!A movement toprovide best-in class solutions. A movement to beempowered. A
Salary Range:CHF122,500.00 - CHF227,500.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland Are you ready to support some of the most important portfolio and development decisions at Novartis? As Associate Director, Portfolio Strategy & Operations, reporting to the Head